References
- Holgate ST, Canonica GW, Simons FER, et al. Consensus group on new generation antihistamines (CONGA): present status and recommendations. Clin Exp Allergy 2003; 33: 1305–24.
- Thompson M, Baylock MG, Sexton DW, Campbell A, Walsh GM. Cetirizine and Levocetirizine inhibit eosinophil transendothelial migration through human dermal or lung micro vascular endothelial cells. Clin Exp Allergy 2002; 32: 1–6.
- Paolieri F, Baltifora M, Riccio A, Beotolini C, Cutolo M, Bloom B. Terfenadine and Fexofenadine reduce in vitro ICAM-I expression in human continuous cell lines. Ann Allergy Asthma Immunol 1998; 81: 601–7.
- Gelfand E, Hua CZ, Takeda K, Kanehiro A, Joetham A. Fexofenadine modulates T cell functions, preventing allergen induced airway inflammation and hyperresponsiveness. J Allergy Clin Immunol 2002; 110: 85–95.
- Potter PC. Levocetirizine is effective for symptom relief including nasal congestion in adolescent and adult PAR, sensitised to house dust mite. Allergy 2003; 58: 893–9.
- Wahn U, Meltzer E, Finn A, et al. Fexofenadine is efficacious and safe in children (6–11 years) with seasonal allergic rhinitis. J Allergy Ciin Immunol 2003; 111: 763–9.
- Potter PC, Van Niekerk C, Scheepers JM. Fexofenadine does not impair reaction time, decision making and driver behaviour. Annals of Allergy 2003; 91: 177–81.
- ETAC Study Group. Allergic factors associated with the development of asthma and the influence of cetirizine in a double blind, randomised, placebo controlled trial: first results of ETAC. Paed Allergy Immunol 1998; 9: 116–24.
- Bousquet J. The new ARIA guidelines: putting science into practice. Clin Exp All Rev 2002; 2: 38–43.
- Allergic rhinitis and its impact on asthma (ARIA). Report in collaboration with the World Health Organization (WHO). J Allergy and Clin Immunol 2001; 1 08(5): Suppl 1.
- Van Cauwenberge P, Juniper EF. Comparison of the efficacy, safety and quality of life provided by Fexofenadine HCI, Loratadine and placebo administered once daily for the treatment of seasonal allergic rhinitis. Clin Exp Allergy 2002; 30(6): 891–99.
- Peters JC, Neslusan C, Crown W, Torres A. Treating allergic rhinitis in patients with co morbid asthma: The risk of asthma related hospitalizations and emergency department visits. J Allergy Clin Immunol 2002; 109: 57–62.
- Kaplan AP. Chronic urticaria: pathogenesis and treatment. Current reviews of allergy and clinical immunology. J Allergy Clin Immunol 2004; 465–75.